US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SIMPLIFY MANAGED FUTURES STRATEGY ETF

30.12

+0.74002.52%

Post-market: 30.120.00000.00%17:03 EDT

Volume:1.13M

Turnover:33.79M

Market Cap:1.50B

PE:- -

High:30.27

Open:29.80

Low:29.80

Close:29.38

52wk High:30.92

52wk Low:26.36

Shares:49.65M

Float Shares:49.65M

Volume Ratio:0.83

T/O Rate:2.27%

Dividend:1.12

Dividend Rate:3.72%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

China Securities Co., Ltd. Bullish on Physical Gold and CTA Strategies, Advises Waiting for Next Equity Cycle

BofA Survey: Investor Cash Holdings Fall Below Key Threshold, Triggering Stock Sell Signal; Potential AI Bubble Seen as Biggest Tail Risk

Nomura strategist warned the market selloff was coming . Here are the forces he says are taking stocks down.

Indonesia Begins Phase I Trials for Its First Inhalable TB Vaccine

Press Release: Fractyl Health Reports Third Quarter 2025 Results; Revita(R) Clinical Momentum Builds Toward 2026 Pivotal Readout and PMA Filing, Cash Runway Extended into Early 2027

Goldman Sachs Top Trader: US Stocks Near CTA Selling Trigger, Market Stability Hinges on Government Reopening

Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights

Hedge Funds for the Masses -- WSJ

Immunocore reports third quarter financial results and provides a business update

DEEPX Wins Two CES 2026 Innovation Awards; Its DX-M1 Powers Best of Innovation Winner ALPON X5 by Sixfab

Li Tiantian Clinches Championship in Financial Digital Innovation Competition

Biodexa announces approval of CTA by EMA of Phase 3 trial in FAP

Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion

Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy

Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

Major Tire Defect Triggers Mass Recall of New Energy Vehicles

China Securities Co., Ltd.: Multi-Strategy, Multi-Asset, Multi-Cycle CTA Investment Strategies

The U.S. Stock Market Rebound is Not a Confidence Vote! Short Covering Creates a 'False Prosperity'; Rally May Be Difficult to Sustain

ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CTA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTA\",,,,,undefined,":{"symbol":"CTA","market":"US","secType":"STK","nameCN":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","latestPrice":30.12,"timestamp":1774641600000,"preClose":29.38,"halted":0,"volume":1127738,"hourTrading":{"tag":"盘后","latestPrice":30.12,"preClose":30.12,"latestTime":"17:03 EDT","volume":38,"amount":1145.11,"timestamp":1774645410640,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02518720217835269,"floatShares":49650001,"shares":49650001,"eps":0,"marketStatus":"Market Closed","change":0.74,"latestTime":"03-27 16:00:00 EDT","open":29.8,"high":30.2723,"low":29.8,"amount":33792721.045948,"amplitude":0.016076,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":29.38,"sharesOutstanding":45800001,"nav":29.5584,"aum":1467576769.38,"dividendRate":0.037165,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":29.89,"preClose":29.38,"latestTime":"09:10 EDT","volume":822,"amount":23823.809814,"timestamp":1774617044213,"change":0.51,"changeRate":0.017359,"amplitude":0.047311},"postHourTrading":{"tag":"盘后","latestPrice":30.12,"preClose":30.12,"latestTime":"17:03 EDT","volume":38,"amount":1145.11,"timestamp":1774645410640,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.833646,"impliedVol":0.118,"impliedVolPercentile":0.6414},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTA\",,,,,undefined,":{"symbol":"CTA","floatShares":49650001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.833646,"shares":49650001,"dividePrice":1.1194,"high":30.2723,"amplitude":0.016076,"preClose":29.38,"low":29.8,"week52Low":26.36,"pbRate":"--","week52High":30.92,"institutionHeld":0,"latestPrice":30.12,"eps":0,"divideRate":0.037165,"volume":1127738,"delay":0,"ttmEps":0,"open":29.8,"prevYearClose":27.26,"prevWeekClose":30.37,"prevMonthClose":30.24,"prevQuarterClose":27.26,"fiveDayClose":30.37,"twentyDayClose":30.24,"sixtyDayClose":27.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTA\",params:#limit:5,,,undefined,":[{"date":"2026-03-26","symbol":"CTA","amount":0.15,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2026-02-24","symbol":"CTA","amount":0.15,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-24","defaultRemindTime":1771943400000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-27","payableDate":"2026-02-24","currency":"USD","dateTimestamp":1771909200000,"payDate":"2026-02-27"},{"date":"2026-01-27","symbol":"CTA","amount":0.1,"announcedDate":"2026-01-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-27","defaultRemindTime":1769524200000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-30","payableDate":"2026-01-27","currency":"USD","dateTimestamp":1769490000000,"payDate":"2026-01-30"},{"date":"2025-11-21","symbol":"CTA","amount":0.1,"announcedDate":"2025-11-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-21","defaultRemindTime":1763735400000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-28","payableDate":"2025-11-21","currency":"USD","dateTimestamp":1763701200000,"payDate":"2025-11-28"},{"date":"2025-10-28","symbol":"CTA","amount":0.1,"announcedDate":"2025-10-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-28","defaultRemindTime":1761658200000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-31","payableDate":"2025-10-28","currency":"USD","dateTimestamp":1761624000000,"payDate":"2025-10-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTA\",market:\"US\",,,undefined,":[{"executeDate":"2022-08-26","recordDate":"2022-08-29","paymentDate":"2022-08-31","value":0.15,"currency":"USD"},{"executeDate":"2022-09-27","recordDate":"2022-09-28","paymentDate":"2022-09-30","value":0.15,"currency":"USD"},{"executeDate":"2022-10-26","recordDate":"2022-10-27","paymentDate":"2022-10-31","value":0.15,"currency":"USD"},{"executeDate":"2022-11-25","recordDate":"2022-11-28","paymentDate":"2022-11-30","value":0.15,"currency":"USD"},{"executeDate":"2022-12-27","recordDate":"2022-12-28","paymentDate":"2022-12-30","value":1.11096,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1149611046","title":"China Securities Co., Ltd. Bullish on Physical Gold and CTA Strategies, Advises Waiting for Next Equity Cycle","url":"https://stock-news.laohu8.com/highlight/detail?id=1149611046","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149611046?lang=en_us&edition=fundamental","pubTime":"2025-12-04 07:41","pubTimestamp":1764805290,"startTime":"0","endTime":"0","summary":"Global multi-asset absolute return portfolios—low-risk and medium-to-high-risk—along with China A-share sector and style rotation strategies posted November returns of -0.16%, -1.04%, and -2.94%,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159831","518880","BK0276","1OZmain","SGCmain","IAU","DUST","NUGT","CTA","GCmain","GLD","GDX","601066","159934","QOmain","SGUmain","MGCmain"],"gpt_icon":1},{"id":"1149945626","title":"BofA Survey: Investor Cash Holdings Fall Below Key Threshold, Triggering Stock Sell Signal; Potential AI Bubble Seen as Biggest Tail Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=1149945626","media":"Stock News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149945626?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:34","pubTimestamp":1763472870,"startTime":"0","endTime":"0","summary":"According to a monthly survey by Bank of America, investors' cash holdings have dropped below a critical threshold, triggering a so-called stock sell signal amid growing concerns over high valuations...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"da7d2b5f7d800a6edfc3e1f1d9c5ee9e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSO","IVV","SDS","ESmain","MESmain","BK4559","BK4585","SH","SPY","BK4581","SPXU","CTA","UPRO","OEF","BK4504","BK4534","BK4588","BK4550","OEX",".SPX"],"gpt_icon":0},{"id":"2583572264","title":"Nomura strategist warned the market selloff was coming . Here are the forces he says are taking stocks down.","url":"https://stock-news.laohu8.com/highlight/detail?id=2583572264","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583572264?lang=en_us&edition=fundamental","pubTime":"2025-11-14 18:38","pubTimestamp":1763116680,"startTime":"0","endTime":"0","summary":"Highly-leveraged ETFs are back to haunt the stock market. Lonely sailing yacht in the ocean at the approaching storm and raining clouds at sunrise, English channel, near French shores. Investors paying attention to Nomura's cross-asset strategist Charlie McElligott would have had an inkling Thursday's market selloff was coming.Filled with terms like gamma and vol puking, market dispatches from the strategist the FT once described as a \"meat-powered market mystic\" do not make for easy reading. But an Oct. 30 note indicated his finger has been on the pulse of troubling undercurrents for markets.Both can weigh on already poorly performing stocks. Granted, the winners struggled on Thursday as well - the Nasdaq COMP, up 18%, this year fell over 2%; the Russell 2000 RUT, which is up only single digits, fell nearly 3%.\"What does negative gamma mean in plain English?It means dealers amplify every move instead of dampening it,\" McGraw said, explaining that when markets start to sell off, those ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1621767737.EUR","BK4115","LU1066053197.SGD","LU1585245621.USD","LU0985481810.HKD","LU1066051225.USD","LU0321505439.SGD","LU1066051498.USD","CTA","LU1914381329.SGD","LU0321505868.SGD","BK4552","LU1699723380.USD","LU0320765646.SGD","BK4534","LU2384288077.EUR","BK4588","LU1621768115.EUR","LU0868494708.USD","LU0225771236.USD","BK4581","BK4515","LU1366192091.USD","IE00BSNM7G36.USD","LU1059921491.USD","LU0306807586.USD","LU0868494617.USD","BK4550","LU1571399168.USD","LU1621767810.EUR","LU0225284248.USD","VZ","LU1066051811.HKD","LU1430594728.SGD","LU0098860793.USD","BK4585","NMR","LU0942090050.USD","BK4127","BK4533","LU1162221912.USD","BK4559","LU1621768206.USD","LU0306806265.USD"],"gpt_icon":0},{"id":"2583574362","title":"Indonesia Begins Phase I Trials for Its First Inhalable TB Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2583574362","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583574362?lang=en_us&edition=fundamental","pubTime":"2025-11-14 17:14","pubTimestamp":1763111663,"startTime":"0","endTime":"0","summary":"Editor’s Choice:Indonesia's Top Court Blocks Police Officers from Taking Civil Posts","market":"nz","thumbnail":"https://statik.tempo.co/data/2020/01/16/id_906598/906598_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2020/01/16/id_906598/906598_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2065725/indonesia-begins-phase-i-trials-for-its-first-inhalable-tb-vaccine","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2065725/indonesia-begins-phase-i-trials-for-its-first-inhalable-tb-vaccine","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["CTA"],"gpt_icon":0},{"id":"2583588485","title":"Press Release: Fractyl Health Reports Third Quarter 2025 Results; Revita(R) Clinical Momentum Builds Toward 2026 Pivotal Readout and PMA Filing, Cash Runway Extended into Early 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2583588485","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583588485?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:06","pubTimestamp":1762981560,"startTime":"0","endTime":"0","summary":"Positive randomized 3-month REMAIN-1 Midpoint Cohort data showed single Revita procedure maintained weight loss after GLP-1 discontinuation; 6-month data expected in Q1 2026. 6-month data from open-label REVEAL-1 Cohort expected in Q4 2025. Topline 6-month data from REMAIN-1 Pivotal Cohort and potential PMA filing expected in H2 2026. $83M in underwritten offerings expected to extend cash runway through upcoming clinical and regulatory milestones and into early 2027. The Company is studying Revita in the REMAIN weight maintenance program, which is designed to evaluate Revita's potential to sustain weight loss following GLP-1 discontinuation. The REMAIN program includes three distinct patient cohorts: the REVEAL-1 Cohort, the REMAIN-1 Midpoint Cohort, and the REMAIN-1 Pivotal Cohort.The REVEAL-1 Cohort  is an open-label study in individuals living with obesity who have lost at least 15% of their total body weight on a GLP-1 medication and who either need or choose to discontinue GLP-1 t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU0170899867.USD","BK4099","LU0882574139.USD","TM","BK4588","BK4006","BK4232","BK4585","LU2746668974.SGD","BK4022","GUTS","03160","BK4604","LU2237443895.HKD","LU2237443549.SGD","IE00BFXG1179.USD","IE00BKVL7J92.USD","LU0149725797.USD","LU2746668461.USD","IE00B1BXHZ80.USD","BK4555","CMC","LU0267386448.USD","LU0971096721.USD","LU2237443465.HKD","LU1363072403.SGD","IE00BZ1G4Q59.USD","LU2237443382.USD","LU2237443978.SGD","CTA","IE00BHPRN162.USD","LU2237443622.USD","R"],"gpt_icon":0},{"id":"1153205513","title":"Goldman Sachs Top Trader: US Stocks Near CTA Selling Trigger, Market Stability Hinges on Government Reopening","url":"https://stock-news.laohu8.com/highlight/detail?id=1153205513","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153205513?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:08","pubTimestamp":1762553339,"startTime":"0","endTime":"0","summary":"Rich Privorotsky, head of Goldman Sachs' Delta-One desk and a top trader, noted a clear \"risk-off\" sentiment during Thursday's US trading session, with selling pressure hitting AI, tech, and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","IE00B19Z3B42.SGD","IE00BFXG1179.USD","IE0034235188.USD","IE0002270589.USD","IE00B19Z3581.USD","LU2471134796.USD","GS","IE0004091025.USD","BK4585","BK4516","LU0345770308.USD","LU2237443978.SGD","LU0048573561.USD","LU1868837300.USD","IE0004086264.USD","LU0061475181.USD","LU1894683348.USD","LU2471134952.CNY","LU2265009873.SGD","LU2237443895.HKD","LU1868836757.USD","BK4533","LU2237443549.SGD","IE00BSNM7G36.USD","LU1868837136.USD","LU2237443622.USD","LU2750360997.AUD","LU2471134523.USD","LU2471134879.HKD","LU2237443465.HKD","LU0251142724.SGD","CTA","LU1804176565.USD","LU2237438978.USD","LU1894683264.USD","BK4588","LU1791807156.HKD","LU0345770993.USD","LU0251131958.USD","LU1668664300.SGD","LU0106831901.USD","LU2237443382.USD","BK4504","LU1868836914.USD","BK4127","LU2750360641.GBP","BK4550","LU0742534661.SGD","LU1868836591.USD","BK4552"],"gpt_icon":0},{"id":"2581311007","title":"Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2581311007","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581311007?lang=en_us&edition=fundamental","pubTime":"2025-11-07 20:00","pubTimestamp":1762516800,"startTime":"0","endTime":"0","summary":"-- New preclinical data for PM577 in Wilson’s Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1’26, with initial clinical data expected in 2027 -- -- Nominated PM647 as deve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183525/0/en/Prime-Medicine-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CF","BK4585","BK4229","BK4588","BK4195","WD","CTA","BK4093"],"gpt_icon":0},{"id":"2581043070","title":"CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2581043070","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581043070?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:05","pubTimestamp":1762463100,"startTime":"0","endTime":"0","summary":"Strengthened balance sheet with private placement of up to $100 million to advance CMP-002, a first-in-class treatment for SYNGAP1-related disorders Initiated Good Laboratory Practice (GLP) toxicology","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/06/3183089/0/en/CAMP4-Reports-Third-Quarter-2025-Financial-Results-and-Corporate-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA","GLP","BK4144","BK4590"],"gpt_icon":0},{"id":"2581736062","title":"Hedge Funds for the Masses -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2581736062","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581736062?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:08","pubTimestamp":1762430880,"startTime":"0","endTime":"0","summary":"This is an online version of Thursday's Markets A.M. newsletter. Get investing insights in your inbox each weekday by signing up here-it's free.Like airlines or fancy hotels, Wall Street has long had a platinum elite membership tier off-limits to the hoi polloi. But is it really worth the money?Other alternative investments might be worth considering, though. Mutual funds called \"liquid alts\" that were supposed to mimic hedge funds boomed for a while, but were expensive and somewhat illiquid. The last few years have seen the launch of cheaper exchange-traded funds that can be easily bought and sold. They could offer better outcomes at lower cost.Like gold or real estate, hedge fund-like ETFs finally seem cheap and liquid enough that sprinkling a small amount into your portfolio makes sense. The jury is still out for the other alternatives that may soon be headed for your 401.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HFND","DBMF","CTA"],"gpt_icon":0},{"id":"2581909528","title":"Immunocore reports third quarter financial results and provides a business update","url":"https://stock-news.laohu8.com/highlight/detail?id=2581909528","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581909528?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:00","pubTimestamp":1762430400,"startTime":"0","endTime":"0","summary":"Immunocore reports third quarter financial results and provides a business update KIMMTRAK (tebentafusp-tebn) net revenues of $103.7 million in 3Q 2025, growing by 29% year-over-year Phase 3 TEBE-AM t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/06/3182351/0/en/Immunocore-reports-third-quarter-financial-results-and-provides-a-business-update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","IE0031619046.USD","IE00B19Z4B17.USD","ORR","LU1093756325.SGD","BK4533","ATOM","LU1093756168.USD","LU2065731478.USD","OS","LU2413666699.HKD","BK4121","BK4567","LU1721428933.USD","LU0347712357.USD","BK4599","BK4588","BK4139","PROC","CRS","LU0963586101.USD","IE00BYQQ9H92.USD","CTA","PFS","IE00B66KJ199.SGD","LU1878469433.USD","BK4548","CM","BK4147","LU2413666426.HKD","BK4007","BK4195","BK4006","IE00BFXG0V08.USD","ALT","IE00B7SZL793.SGD","BK4585","LU2211817866.USD","MTD","BK4207","BK4187","BK4097"],"gpt_icon":0},{"id":"2581730407","title":"DEEPX Wins Two CES 2026 Innovation Awards; Its DX-M1 Powers Best of Innovation Winner ALPON X5 by Sixfab","url":"https://stock-news.laohu8.com/highlight/detail?id=2581730407","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581730407?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:53","pubTimestamp":1762350780,"startTime":"0","endTime":"0","summary":"SEOUL, South Korea, Nov. 5, 2025 /PRNewswire/ -- Global AI semiconductor company DEEPX  announced that it has won two CES 2026 Innovation Awards, while Sixfab, a US-based IoT and edge computing company, received the Best of Innovation award — CES's highest honor — for its AI gateway ALPON X5 powered by DEEPX's DX-M1. This milestone demonstrates how DEEPX's solutions are further solidifying its position as the global standard for 'Physical AI' whilestrengthening its global partner ecosystem.Over the past three years, DEEPX has demonstrated both its technological innovation and market competitiveness on the global stage.At CES 2024, DEEPX became the first AI semiconductor company to achieve a triple crown, winning Innovation Awards in the Robotics, Embedded Technology, and Hardware Components categories with its first-generation AI chipset, the DX-M1.","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2814551/image.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2814551/image.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/deepx-wins-two-ces-2026-innovation-awards-its-dx-m1-powers-best-of-innovation-winner-alpon-x5-by-sixfab-302605701.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AI","BK4110","BK4543","BK4023","BK4551","CTA","BK4528","DX","BK4588","BK4587","BK4585"],"gpt_icon":0},{"id":"1141279275","title":"Li Tiantian Clinches Championship in Financial Digital Innovation Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=1141279275","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141279275?lang=en_us&edition=fundamental","pubTime":"2025-11-04 19:41","pubTimestamp":1762256469,"startTime":"0","endTime":"0","summary":"From November 2nd to 3rd, the inaugural Financial Digital Innovation Competition for Transportation Enterprises was successfully held in Changsha. Li Tiantian, a participant from the Hubei Expressway...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA","BK4008","CPA","LU1236620834.HKD","LU1236620750.USD","BK4500"],"gpt_icon":0},{"id":"2580215077","title":"Biodexa announces approval of CTA by EMA of Phase 3 trial in FAP","url":"https://stock-news.laohu8.com/highlight/detail?id=2580215077","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580215077?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:35","pubTimestamp":1762176920,"startTime":"0","endTime":"0","summary":"Biodexa Pharmaceuticals (BDRX) announced the approval of a Clinical Trial Application, CTA, by the European Medicines Agency, EMA, of its Phase 3 S...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biodexa-announces-approval-of-cta-by-ema-of-phase-3-trial-in-fap-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biodexa-announces-approval-of-cta-by-ema-of-phase-3-trial-in-fap-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EMA","CTA","BK4139","BK4081","BDRX"],"gpt_icon":0},{"id":"2580421667","title":"Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2580421667","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580421667?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:30","pubTimestamp":1762176600,"startTime":"0","endTime":"0","summary":"November 3, 2025 Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/03/3179260/0/en/Biodexa-Announces-Approval-of-CTA-in-Europe-for-Phase-3-Serenta-Trial-in-FAP-First-European-patient-expected-to-be-enrolled-in-4Q-2025-Addressable-US-European-Market-Put-at-7-Billi.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA","BK4081","EMA","BDRX","BK4139"],"gpt_icon":0},{"id":"2579172565","title":"Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2579172565","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579172565?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:01","pubTimestamp":1761854460,"startTime":"0","endTime":"0","summary":"-- Webcast event to begin at 8:00am ET on Wednesday, November 12, 2025 --CAMBRIDGE, Mass., Oct.  30, 2025  (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/30/3177878/0/en/Prime-Medicine-to-Host-Virtual-KOL-Event-to-Showcase-Wilson-s-Disease-Strategy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","CTA","BK4585","BK4588","BK4218","HST","KOL"],"gpt_icon":0},{"id":"2579317751","title":"Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2579317751","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579317751?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:15","pubTimestamp":1761768900,"startTime":"0","endTime":"0","summary":"Dose-dependent mean reductions of Activin E of up to 85% one month post single dose of WVE-007 in INLIGHT clinical trial, exceeding levels that led to weight loss in preclinical models; WVE-007 is gen","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/29/3176880/0/en/Wave-Life-Sciences-Announced-Positive-Target-Engagement-Data-from-INLIGHT-Clinical-Trial-of-WVE-007-for-Obesity-During-Annual-Research-Day.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WVE","CTA","RNA","BK4505","BK4139","BK4588","BK4585","BK4007"],"gpt_icon":0},{"id":"1128794179","title":"Major Tire Defect Triggers Mass Recall of New Energy Vehicles","url":"https://stock-news.laohu8.com/highlight/detail?id=1128794179","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128794179?lang=en_us&edition=fundamental","pubTime":"2025-10-27 14:20","pubTimestamp":1761546054,"startTime":"0","endTime":"0","summary":"Recently, a tire recall initiated by Continental Tire Americas (CTA) has sparked a chain reaction throughout the automotive supply chain. Due to safety risks associated with tread separation in some...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0980610538.SGD","BK4022","LU0345770993.USD","LU0130103400.USD","BK4574","GM","BK4585","LU0130517989.USD","BK4099","BK4230","BK4561","LU0070302665.USD","LU0477156953.USD","BK4588","BK4566","LU0162691827.USD","BK4559","LU0345770308.USD","LU0208291251.USD","HTZ","CTA","LU0320765489.SGD","LU0648000940.SGD","LU0477156797.USD","LU0072461881.USD","LU1201861249.SGD","LU0648001328.SGD","BK4555","LU0130102774.USD","BK4516","LU0130518102.USD","LU1201861165.SGD","LU0006061336.USD","BK4596","LU0211331839.USD"],"gpt_icon":1},{"id":"1162430747","title":"China Securities Co., Ltd.: Multi-Strategy, Multi-Asset, Multi-Cycle CTA Investment Strategies","url":"https://stock-news.laohu8.com/highlight/detail?id=1162430747","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162430747?lang=en_us&edition=fundamental","pubTime":"2025-10-23 22:32","pubTimestamp":1761229929,"startTime":"0","endTime":"0","summary":"(Source: China Securities Co., Ltd. Wealth Management) In the context of global economic uncertainty and increasing volatility in traditional stock and bond markets, how can investors construct a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601066","CTA","BK0276","160921"],"gpt_icon":0},{"id":"1147411802","title":"The U.S. Stock Market Rebound is Not a Confidence Vote! Short Covering Creates a 'False Prosperity'; Rally May Be Difficult to Sustain","url":"https://stock-news.laohu8.com/highlight/detail?id=1147411802","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147411802?lang=en_us&edition=fundamental","pubTime":"2025-10-21 19:00","pubTimestamp":1761044438,"startTime":"0","endTime":"0","summary":"According to Zhitor Finance APP, as the U.S. stock market rebounds from sell-offs amidst ongoing uncertainties, the driving force behind this rally often hides a key player - aggressive buyers forced...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","CTA","UPRO","BK4585","ESmain","BK4588","BK4559","MESmain","SSO","SDS","BK4504","OEX","OEF",".SPX","IVV","SH","BK4550","SPXU","BK4534","SPY"],"gpt_icon":0},{"id":"2576851061","title":"ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576851061","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576851061?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:00","pubTimestamp":1760961600,"startTime":"0","endTime":"0","summary":"LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct.  20, 2025  (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/20/3169294/33039/en/ProQR-Receives-CTA-Authorization-for-AX-0810-and-Announces-Virtual-Investor-and-Analyst-Event-on-November-3-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1543694498.USD","G","BK4121","LU0702159343.USD","BK4567","LU1165135440.EUR","BK4181","BK4139","EMA","BK4505","LU2229751404.USD","LU2360107671.USD","LU1721428933.USD","LU2413666699.HKD","PK","LU1169589451.USD","RNA","LU0702159699.USD","BK4226","PD","LU2089279066.USD","LU2413666426.HKD","LU2041044095.USD","LU1166156734.SGD","LU2092937221.SGD","BK4585","LU1861217088.USD","LU1861220207.SGD","AX","IE00BN0W2T93.GBP","LU1169590202.USD","CTA","BK4106","BK4023","BK4081","LU0347712357.USD","BK4211","BK4218","BK4588","IE00BN0W2W23.USD","BK4195","IE00BN0W2V16.EUR","BK4523","A"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}]}}